EFG Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.05M Buy
27,634
+16,887
+157% +$1.71M 0.27% 141
2025
Q2
$1.39M Buy
+10,747
New +$1.56M 0.2% 155
2024
Q2
Sell
-7,232
Closed -$1.56M 201
2024
Q1
$1.56M Buy
7,232
+1,788
+33% +$350K 0.27% 150
2023
Q4
$1.11M Sell
5,444
-2,119
-28% -$343K 0.21% 167
2023
Q3
$1.5M Sell
7,563
-558
-7% -$141K 0.36% 100
2023
Q2
$2.64M Buy
8,121
+118
+1% +$33.7K 0.57% 60
2023
Q1
$1.87M Sell
8,003
-1,856
-19% -$469K 0.41% 79
2022
Q4
$2.5M Sell
9,859
-1,260
-11% -$269K 0.56% 63
2022
Q3
$1.98M Buy
11,119
+585
+6% +$118K 0.46% 73
2022
Q2
$1.93M Sell
10,534
-904
-8% -$180K 0.41% 78
2022
Q1
$2.94M Sell
11,438
-102
-0.9% -$23.3K 0.44% 65
2021
Q4
$2.65M Buy
+11,540
New +$2.82M 0.35% 86

Other funds holding INSP

EFG Asset Management's INSP Position: Q3 2025 in Review

EFG Asset Management increased its Inspire Medical Systems (INSP) stake by 157% in Q3 2025, buying an estimated $1.71M and bringing the position to 27,634 shares worth $2.05M. The position accounts for 0.27% of the portfolio, ranked #141.

EFG Asset Management first reported a position in INSP in Q4 2021 and has held it in 12 quarters since. The position peaked at $2.94M in Q1 2022. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • EFG Asset Management held 27,634 shares of Inspire Medical Systems worth $2.05M as of Q3 2025.
  • EFG Asset Management bought 16,887 Inspire Medical Systems shares in Q3 2025, an estimated $1.71M.
  • Inspire Medical Systems made up 0.27% of EFG Asset Management's portfolio in Q3 2025, its #141 holding.
  • EFG Asset Management first reported a position in Inspire Medical Systems in Q4 2021 and has held it in 12 quarters since.
  • EFG Asset Management's Inspire Medical Systems position peaked at $2.94M in Q1 2022.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on EFG Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.